Capr Stock Drop Alert: Capricor Therapeutics Stock Plummets Over 64% After FDA Briefing Documents Raise Concerns, Triggering Securities Fraud Investigation by BFA Law Business Wire (Press Release) 7h
Capricor Therapeutics Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel Business Wire (Press Release) 8h
Capricor Therapeutics Stock Tanks 54% Over FDA Panel's Negative Vote On Deramiocel Effectiveness RTT News 9h
FDA advisers dismiss safety warnings, back 4 peptide treatments Dermatology Advisor 2d Pharma Health All sources
FDA AdCom shuns Capricor’s DMD cell therapy amid data dispute Pharmaceutical Technology 9h Capricor Therapeutics Duchenne Pharma All sources
‘Be realistic, we’re in India’: Bombay High Court quashes suspension of hotel licence by FDA over hygiene The Hindu 15h Mumbai India Article paywall All sources
FDA approves first OTC acetaminophen/Naproxen Sodium fixed-dose tablet Renal and Urology News 2d Tylenol Pharma All sources
